Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Prognostic Factors for Adrenocortical Carcinoma Outcomes
Claudia Scollo, Marco Russo, Maria Antonietta Trovato, et al.
Frontiers in Endocrinology (2016) Vol. 7
Open Access | Times Cited: 48

Showing 1-25 of 48 citing articles:

The Adult Adrenal Cortex Undergoes Rapid Tissue Renewal in a Sex-Specific Manner
Anaëlle Grabek, Bastien Dolfi, Bryan Klein, et al.
Cell stem cell (2019) Vol. 25, Iss. 2, pp. 290-296.e2
Closed Access | Times Cited: 103
Role of microRNAs in endocrine cancer metastasis
Cilene Rebouças Lima, Cibele Crastequini Gomes, Marinilce Fagundes dos Santos
Molecular and Cellular Endocrinology (2017) Vol. 456, pp. 62-75
Open Access | Times Cited: 66
Predictors of Survival in Adrenocortical Carcinoma: An Analysis From the National Cancer Database
Sri Harsha Tella, Anuhya Kommalapati, Subhashini Yaturu, et al.
The Journal of Clinical Endocrinology & Metabolism (2018) Vol. 103, Iss. 9, pp. 3566-3573
Open Access | Times Cited: 64
Targeted Assessment of G0S2 Methylation Identifies a Rapidly Recurrent, Routinely Fatal Molecular Subtype of Adrenocortical Carcinoma
Dipika R. Mohan, Antônio Marcondes Lerário, Tobias Else, et al.
Clinical Cancer Research (2019) Vol. 25, Iss. 11, pp. 3276-3288
Open Access | Times Cited: 56
A nomogram for individualized estimation of survival among adult patients with adrenocortical carcinoma after surgery: a retrospective analysis and multicenter validation study
Jianqiu Kong, Junjiong Zheng, Jinhua Cai, et al.
Cancer Communications (2019) Vol. 39, Iss. 1
Open Access | Times Cited: 47
The Sexually Dimorphic Adrenal Cortex: Implications for Adrenal Disease
Rodanthi Lyraki, Andreas Schedl
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 9, pp. 4889-4889
Open Access | Times Cited: 34
Adrenocortical Carcinomas: Molecular Pathogenesis, Treatment Options, and Emerging Immunotherapy and Targeted Therapy Approaches
Divya Chukkalore, Kira MacDougall, Viraj A. Master, et al.
The Oncologist (2024) Vol. 29, Iss. 9, pp. 738-746
Open Access | Times Cited: 6
Laparoscopic Versus Open Adrenalectomy for Localized/Locally Advanced Primary Adrenocortical Carcinoma (ENSAT I–III) in Adults: Is Margin-Free Resection the Key Surgical Factor that Dictates Outcome? A Review of the Literature
Eustratia Mpaili, Demetrios Moris, Diamantis I. Tsilimigras, et al.
Journal of Laparoendoscopic & Advanced Surgical Techniques (2018) Vol. 28, Iss. 4, pp. 408-414
Closed Access | Times Cited: 40
Adrenocortical carcinoma: current state of the art, ongoing controversies, and future directions in diagnosis and treatment
Omair A. Shariq, Travis J. McKenzie
Therapeutic Advances in Chronic Disease (2021) Vol. 12
Open Access | Times Cited: 31
Crosstalk between androgen receptor and WNT/β-catenin signaling causes sex-specific adrenocortical hyperplasia in mice
Rodanthi Lyraki, Anaëlle Grabek, Amélie Tison, et al.
Disease Models & Mechanisms (2023) Vol. 16, Iss. 6
Open Access | Times Cited: 12
Adrenal Cortical Carcinoma

American Registry of PathologyArlington, Virginia eBooks (2024), pp. 131-183
Closed Access | Times Cited: 4
Prognostic Factors of Adrenocortical Carcinoma: An Analysis of the Surveillance Epidemiology and End Results (SEER) Database
Sen Wang, Sansan Chen, Weicheng Gao, et al.
PubMed (2017) Vol. 18, Iss. 10, pp. 2817-2823
Closed Access | Times Cited: 34
Update on Adrenocortical Carcinoma
Zahra Sarrafan-Chaharsoughi, Pouria Yazdian Anari, Ashkan A. Malayeri, et al.
Urologic Clinics of North America (2025) Vol. 52, Iss. 2, pp. 275-286
Closed Access
Lead (II) removal by poly(N,N-dimethylacrylamide-co-2-hydroxyethyl methacrylate)
A.L. Ramos-Jacques, J. Armando Luján‐Montelongo, Carolina Silva-Cuevas, et al.
European Polymer Journal (2018) Vol. 101, pp. 262-272
Closed Access | Times Cited: 29
Raman Imaging and Fluorescence Lifetime Imaging Microscopy for Diagnosis of Cancer State and Metabolic Monitoring
Lucas Becker, Nicole Janssen, Shannon L. Layland, et al.
Cancers (2021) Vol. 13, Iss. 22, pp. 5682-5682
Open Access | Times Cited: 22
Expression of SOAT1 in Adrenocortical Carcinoma and Response to Mitotane Monotherapy: An ENSAT Multicenter Study
Isabel Weigand, Barbara Altieri, Amanda Meneses Ferreira Lacombe, et al.
The Journal of Clinical Endocrinology & Metabolism (2020) Vol. 105, Iss. 8, pp. 2642-2653
Open Access | Times Cited: 21
Primary site surgery for metastatic adrenocortical carcinoma improves survival outcomes: an analysis of a population-based database
Sen Wang, Weicheng Gao, Sansan Chen, et al.
OncoTargets and Therapy (2017) Vol. Volume 10, pp. 5311-5315
Open Access | Times Cited: 22
Ki67 in endocrine neoplasms: to count or not to count, this is the question! A systematic review from the English language literature
Elia Guadagno, Elena d’Avella, Paolo Cappabianca, et al.
Journal of Endocrinological Investigation (2020) Vol. 43, Iss. 10, pp. 1429-1445
Closed Access | Times Cited: 19
Asymmetric Adrenals: Sexual Dimorphism of Adrenal Tumors
Nicole Bechmann, Mats Leif Moskopp, Georgiana Constantinescu, et al.
The Journal of Clinical Endocrinology & Metabolism (2023) Vol. 109, Iss. 2, pp. 471-482
Open Access | Times Cited: 7
Surface functionalized nanomaterial systems for targeted therapy of endocrine related tumors: a review of recent advancements
Limei Liu, Miao Yang, Ziyang Chen
Drug Delivery (2024) Vol. 31, Iss. 1
Open Access | Times Cited: 2
A Review on Mitotane: A Target Therapy in Adrenocortical Carcinoma
Fabiano Flauto, Maria Cristina De Martino, Chiara Vitiello, et al.
Cancers (2024) Vol. 16, Iss. 23, pp. 4061-4061
Open Access | Times Cited: 2
The Emerging Role of m6A Modification in Endocrine Cancer
Xiaoyu Ji, Zhiyuan Wang, Wei Sun, et al.
Cancers (2023) Vol. 15, Iss. 4, pp. 1033-1033
Open Access | Times Cited: 6
Minimally invasive versus open adrenalectomy for adrenocortical carcinoma: the keys surgical factors influencing the outcomes—a collective overview
Alessio Giordano, Francesco Feroci, Mauro Podda, et al.
Langenbeck s Archives of Surgery (2023) Vol. 408, Iss. 1
Closed Access | Times Cited: 5
Reassessing the impact of tumor size on operative approach in adrenocortical carcinoma
Jonathan J. Hue, Katherine Bingmer, Heming H Zhao, et al.
Journal of Surgical Oncology (2021) Vol. 123, Iss. 5, pp. 1238-1245
Closed Access | Times Cited: 12
The construction and analysis of tumor-infiltrating immune cells and ceRNA networks in metastatic adrenal cortical carcinoma
Runzhi Huang, Ziqi Liu, Tingli Tian, et al.
Bioscience Reports (2020) Vol. 40, Iss. 3
Open Access | Times Cited: 12
Page 1 - Next Page

Scroll to top